BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 19045653)

  • 21. Observations of Distortion Product Otoacoustic Emission Components in Adults With Hearing Loss.
    Prieve BA; Thomas L; Long G; Talmadge C
    Ear Hear; 2020; 41(3):652-662. PubMed ID: 31569117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indications of different distortion product otoacoustic emission mechanisms from a detailed f1,f2 area study.
    Knight RD; Kemp DT
    J Acoust Soc Am; 2000 Jan; 107(1):457-73. PubMed ID: 10641654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for the distortion product frequency place as a source of distortion product otoacoustic emission (DPOAE) fine structure in humans. II. Fine structure for different shapes of cochlear hearing loss.
    Mauermann M; Uppenkamp S; van Hengel PW; Kollmeier B
    J Acoust Soc Am; 1999 Dec; 106(6):3484-91. PubMed ID: 10615688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distortion product otoacoustic emission contralateral suppression functions obtained with ramped stimuli.
    Purcell DW; Butler BE; Saunders TJ; Allen P
    J Acoust Soc Am; 2008 Oct; 124(4):2133-48. PubMed ID: 19062854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dependence of the DPOAE amplitude pattern on acoustical biasing of the cochlear partition.
    Lukashkin AN; Russell IJ
    Hear Res; 2005 May; 203(1-2):45-53. PubMed ID: 15855029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of short-term tone exposure on DPOAEs].
    Shi Y; Jiang S; Gu R
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Feb; 32(1):41-4. PubMed ID: 10743127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distortion product emission latency in normal hearing adults.
    Marques Vde V; Azevedo MF
    Pro Fono; 2004; 16(2):203-8. PubMed ID: 15311745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimates of cochlear compression using distortion product otoacoustic emissions and growth of forward masking.
    Moore TM; Hood LJ; Hornsby BW
    Ear Hear; 2014; 35(6):711-4. PubMed ID: 25083597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ["Single generator distortion products"(sgDPOAE). Precise measurements of distortion product otoacoustic emissions by three-tone stimulations].
    Plinkert PK; Heitmann J; Waldmann B
    HNO; 1997 Nov; 45(11):909-14. PubMed ID: 9476103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender, music, and distortion product otoacoustic emission components.
    Torre P; Grace J; Hansen C; Millman P; Martin H
    Ear Hear; 2013; 34(6):e74-81. PubMed ID: 23698624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Test-retest repeatability of distortion product otoacoustic emissions.
    Wagner W; Heppelmann G; Vonthein R; Zenner HP
    Ear Hear; 2008 Jun; 29(3):378-91. PubMed ID: 18382378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Level dependence of the nonlinear-distortion component of distortion-product otoacoustic emissions in humans.
    Zelle D; Thiericke JP; Dalhoff E; Gummer AW
    J Acoust Soc Am; 2015 Dec; 138(6):3475-90. PubMed ID: 26723305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model.
    Dille MF; McMillan GP; Reavis KM; Jacobs P; Fausti SA; Konrad-Martin D
    J Acoust Soc Am; 2010 Sep; 128(3):1163-74. PubMed ID: 20815453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Locally weighted least squares estimation of DPOAE evoked by continuously sweeping primaries].
    Han X; Fu X; Cui J; Xiao L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Dec; 30(6):1153-8, 1170. PubMed ID: 24645587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distortion product otoacoustic emissions: a time domain analysis.
    Duifhuis H
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(6):340-6. PubMed ID: 17065827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigating the wave-fixed and place-fixed origins of the 2f(1)-f(2) distortion product otoacoustic emission within a micromechanical cochlear model.
    Young JA; Elliott SJ; Lineton B
    J Acoust Soc Am; 2012 Jun; 131(6):4699-709. PubMed ID: 22712943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmission of infrasonic pressure waves from cerebrospinal to intralabyrinthine fluids through the human cochlear aqueduct: Non-invasive measurements with otoacoustic emissions.
    Traboulsi R; Avan P
    Hear Res; 2007 Nov; 233(1-2):30-9. PubMed ID: 17716844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contralateral acoustic stimulation alters the magnitude and phase of distortion product otoacoustic emissions.
    Deeter R; Abel R; Calandruccio L; Dhar S
    J Acoust Soc Am; 2009 Nov; 126(5):2413-24. PubMed ID: 19894823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research on DPOAE of guinea pigs treated with gentamicin].
    Ye L; Tao Z; Hua Q; Xiao B
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):57-60. PubMed ID: 18435257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distortion product otoacoustic emissions during the first year in term infants: a longitudinal study.
    Zang Z; Jiang ZD
    Brain Dev; 2007 Jul; 29(6):346-51. PubMed ID: 17113742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.